N-prop-2-ynyl carboxamide derivatives and their use as TRPA1 antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9533952
APP PUB NO 20150376130A1
SERIAL NO

14674940

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Compounds of formula I, wherein A, B, X, Z and R1-R6, are as defined in the claims, exhibit TRPA 1 activity and are thus useful as TRPA1 modulators.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ORION CORPORATION02200 ESPOO

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Arvela, Riina Turku, FI 2 2
Heikkinen, Terhi Lieto, FI 7 37
Holm, Patrik Lielahti, FI 21 50
Prusis, Peteris Turku, FI 3 5
Roslund, Mattias Turku, FI 2 36
Salo, Harri Turku, FI 25 147

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 3, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00